Please login to the form below

Not currently logged in
Email:
Password:

Celgene’s CEO Mark Alles is appointed as chairman

He succeeds Bob Hugin who is retiring from the pharma firm

Executive chairman Bob Hugin has decided to retire from Celgene after 19 years of service and will step down from the board of directors effective 5 February.

Hugin initially joined Celgene as its chief financial officer and then subsequently became chief operating officer and chief executive officer.

His successor will be Celgene’s current chief executive officer Mark Alles, who will remain as CEO along side his new position as the chairman of the board of directors.

Alles has been with Celgene since 2004, holding roles such as chief operational officer and executive vice president, global head of haematology and oncology.

Michael Casey, Celgene’s lead independent director, said: “Mark is a tremendous leader and the best person to guide Celgene into its next phase of significant growth.

“Through his strategic leadership as CEO, Celgene has advanced and expanded its portfolio of potentially life-changing medicines.”

6th February 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....